United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 13, 2026 · Filed May 14, 2026

On May 13, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$578.65 for US$5.5M under a trading plan, leaving 40,513 shares. Filed May 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$578.65 average (US$575.40 to US$583.81)
Value
US$5.5M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 13, 2026Common StockSale1,378US$575.4048,635Direct
May 13, 2026Common StockSale624US$576.3448,011Direct
May 13, 2026Common StockSale1,567US$577.5846,444Direct
May 13, 2026Common StockSale1,874US$578.6344,570Direct
May 13, 2026Common StockSale1,752US$579.5842,818Direct
May 13, 2026Common StockSale1,494US$580.5041,324Direct
May 13, 2026Common StockSale371US$581.5240,953Direct
May 13, 2026Common StockSale80US$582.3240,873Direct
May 13, 2026Common StockSale360US$583.8140,513Direct

Source

View original at SEC

Related